Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Mohamad Ayub Khan Sharzehan"'
Publikováno v:
British Journal of Biomedical Science, Vol 81 (2024)
Background: Publications on the associations of genetic variants with the response to platinum-based chemotherapy (PBC) in NSCLC patients have surged over the years, but the results have been inconsistent. Here, a comprehensive meta-analysis was cond
Externí odkaz:
https://doaj.org/article/16cc46719a5c4c53bab64c560d96bcbb
Autor:
Mohamad Ayub Khan Sharzehan, Hilary Sito, Noraidatulakma Abdullah, Athanasios Alexiou, Marios Papadakis, Rahman Jamal, Shing Cheng Tan
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-26 (2022)
Abstract CYP2E1 encodes an enzyme that participates in the activation of several carcinogenic substances. Thus, numerous studies have investigated the association between CYP2E1 polymorphisms and colorectal cancer (CRC) risk, but inconclusive results
Externí odkaz:
https://doaj.org/article/cabdfa3dbd8e4f2e8ed99954230154f4
Autor:
Shing Cheng Tan, Teck Yew Low, Ezanee Azlina Mohamad Hanif, Mohamad Ayub Khan Sharzehan, Hamed Kord-Varkaneh, Md Asiful Islam
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Abstract The ESR1 rs9340799 polymorphism has been frequently investigated with regard to its association with breast cancer (BC) susceptibility, but the findings have been inconclusive. In this work, we aimed to address the inconsistencies in study f
Externí odkaz:
https://doaj.org/article/19da81a27c5a4b1188960db30747bbc6
Autor:
Shing Cheng Tan, Teck Yew Low, Hafiz Muhammad Jafar Hussain, Mohamad Ayub Khan Sharzehan, Hilary Sito, Hamed Kord-Varkaneh, Md Asiful Islam
Publikováno v:
PLoS ONE, Vol 17, Iss 10 (2022)
Background The XRCC3 p.Thr241Met (rs861539) polymorphism has been extensively studied for its association with glioma risk, but results remain conflicting. Therefore, we performed a systematic review and meta-analysis to resolve this inconsistency. M
Externí odkaz:
https://doaj.org/article/ddc485e8450c44f1a874324febdc8d85
Autor:
Shing Cheng Tan, Hui-min Neoh, Mia Yang Ang, Mohamad Ayub Khan Sharzehan, Nursyazwani Omar, Teck Yew Low
Publikováno v:
Translational Bioinformatics ISBN: 9789811678929
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e969437c4ab2d9cc0592d06efb49e57b
https://doi.org/10.1007/978-981-16-7893-6_11
https://doi.org/10.1007/978-981-16-7893-6_11
Autor:
Shing Cheng Tan, Teck Yew Low, Hafiz Muhammad Jafar Hussain, Mohamad Ayub Khan Sharzehan, Hilary Sito, Hamed Kord-Varkaneh, Md Asiful Islam
Publikováno v:
PloS one. 17(10)
Background The XRCC3 p.Thr241Met (rs861539) polymorphism has been extensively studied for its association with glioma risk, but results remain conflicting. Therefore, we performed a systematic review and meta-analysis to resolve this inconsistency. M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2d1bc26186735a2d6ffb74528626fd2
https://pubmed.ncbi.nlm.nih.gov/36264998
https://pubmed.ncbi.nlm.nih.gov/36264998
Autor:
Hamed Kord-Varkaneh, Teck Yew Low, Ezanee Azlina Mohamad Hanif, Shing Cheng Tan, Mohamad Ayub Khan Sharzehan, Asiful Islam
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Scientific Reports
Scientific Reports
The ESR1 rs9340799 polymorphism has been frequently investigated with regard to its association with breast cancer (BC) susceptibility, but the findings have been inconclusive. In this work, we aimed to address the inconsistencies in study findings b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::edcefc90cda4976719697ec1100d97f0
https://doi.org/10.1038/s41598-021-97935-8
https://doi.org/10.1038/s41598-021-97935-8